BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31520644)

  • 1. Quantification of ENT1 and ENT2 Proteins at the Placental Barrier and Contribution of These Transporters to Ribavirin Uptake.
    Nishimura T; Sano Y; Takahashi Y; Noguchi S; Uchida Y; Takagi A; Tanaka T; Katakura S; Nakashima E; Tachikawa M; Maruyama T; Terasaki T; Tomi M
    J Pharm Sci; 2019 Dec; 108(12):3917-3922. PubMed ID: 31520644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of equilibrative nucleoside transporter (ENT) 2 to fluorouracil transport in rat placental trophoblast cells.
    Takagi A; Nishimura T; Akashi T; Tomi M; Nakashima E
    Drug Metab Pharmacokinet; 2017 Apr; 32(2):151-156. PubMed ID: 28209435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of nucleoside uptake in rat placenta and induction of placental CNT2 in experimental diabetes.
    Nishimura T; Chishu T; Tomi M; Nakamura R; Sato K; Kose N; Sai Y; Nakashima E
    Drug Metab Pharmacokinet; 2012; 27(4):439-46. PubMed ID: 22354287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equilibrative Nucleoside Transporter 1 (ENT1,
    Cerveny L; Ptackova Z; Ceckova M; Karahoda R; Karbanova S; Jiraskova L; Greenwood SL; Glazier JD; Staud F
    Drug Metab Dispos; 2018 Nov; 46(11):1817-1826. PubMed ID: 30097436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influx mechanism of 2',3'-dideoxyinosine and uridine at the blood-placenta barrier.
    Sato K; Sai Y; Nishimura T; Chishu T; Shimpo S; Kose N; Nakashima E
    Placenta; 2009 Mar; 30(3):263-9. PubMed ID: 19135251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2.
    Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M
    Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
    Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
    Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
    Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain.
    Kiss A; Farah K; Kim J; Garriock RJ; Drysdale TA; Hammond JR
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):363-72. PubMed ID: 11085929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.
    Miller SR; McGrath ME; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Mol Pharmacol; 2021 Dec; 100(6):548-557. PubMed ID: 34503974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport of ribavirin across the rat and human placental barrier: Roles of nucleoside and ATP-binding cassette drug efflux transporters.
    Karbanova S; Cerveny L; Jiraskova L; Karahoda R; Ceckova M; Ptackova Z; Staud F
    Biochem Pharmacol; 2019 May; 163():60-70. PubMed ID: 30716294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
    Hammond JR
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine.
    Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP
    Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Drug Transporters Contribute to the Placental Transfer of Emtricitabine.
    Zeng Q; Bai M; Li C; Lu S; Ma Z; Zhao Y; Zhou H; Jiang H; Sun D; Zheng C
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ribavirin uptake systems in human hepatocytes.
    Fukuchi Y; Furihata T; Hashizume M; Iikura M; Chiba K
    J Hepatol; 2010 Apr; 52(4):486-92. PubMed ID: 20185188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).
    Playa H; Lewis TA; Ting A; Suh BC; Muñoz B; Matuza R; Passer BJ; Schreiber SL; Buolamwini JK
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5801-5804. PubMed ID: 25454272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter.
    Bone DB; Hammond JR
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3325-32. PubMed ID: 17921321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Computational Approaches for Predicting Drug Interactions with Human Equilibrative Nucleoside Transporter 1.
    Miller SR; Lane TR; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Drug Metab Dispos; 2021 Jul; 49(7):479-489. PubMed ID: 33980604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside/nucleobase transport and metabolism by microvascular endothelial cells isolated from ENT1-/- mice.
    Bone DB; Choi DS; Coe IR; Hammond JR
    Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H847-56. PubMed ID: 20543083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
    Ward JL; Sherali A; Mo ZP; Tse CM
    J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.